Upstream Bio Statistics
NASDAQ: UPBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.61+0.02 (+0.44%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 4.61 0.00%
Upstream Bio by the numbers
Upstream Bio has a market capitalization of $252.5 million based on 54.77M shares outstanding. With trailing EPS of $-2.88, Upstream Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.5% below its 50-day average and 60.2% below its 200-day average.
Average daily trading volume is 605.81K shares, or about $2.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
UPB valuation vs. peer median
| Metric | UPB | Peer median | Difference |
|---|---|---|---|
| Market cap | $252.49M | $249.97M | +1% |
| Avg. volume | 605.81K | 326.46K | +86% |
Peer median across 8 companies: ZNTL, IMRX, AMRN, ACIU, LFCR, VCRE, AKBA, BCYC.
Valuation
- Market cap
- $252.49M
- EPS (TTM)
- $-2.88
- Shares outstanding
- 54.77M
Price and trading
- Previous close
- 4.59
- Open
- 4.55
- Day range
- 4.50 – 4.72
- 52-week range
- 4.50 – 33.68
- 52-week change
- -75.31%
- Beta
- —
- Volume
- 908.40K
- Average volume
- 605.81K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 252.49M
- Forward Pe
- -1.65
- Eps
- -2.88
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 33.68
- Week52 Low
- 4.50
- Avg Volume
- 605.81K
- Shares Outstanding
- 54.77M
- Ma50
- 6.19
- Ma200
- 11.59
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -86.31%
- Pct From52w Low
- 2.44%